NxStage Medical Inc.
NXTM
NXTM was delisted on the 21st of February, 2019.
178 hedge funds and large institutions have $1.39B invested in NxStage Medical Inc. in 2017 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 62 increasing their positions, 50 reducing their positions, and 25 closing their positions.
175% more funds holding in top 10
Funds holding in top 10: 4 → 11 (+7)
48% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 25
24% more repeat investments, than reductions
Existing positions increased: 62 | Existing positions reduced: 50
6% more funds holding
Funds holding: 168 → 178 (+10)
14% less capital invested
Capital invested by funds: $1.61B → $1.39B (-$219M)
73% less call options, than puts
Call options by funds: $1.92M | Put options by funds: $7.12M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TAL
TIG Advisors LLC
New York
|
+$22.8M |
| 2 |
AWG
Alpha Wave Global
New York
|
+$20.8M |
| 3 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
+$15M |
| 4 |
AGM
Alpine Global Management
New York
|
+$10.9M |
| 5 |
HS
HighVista Strategies
Boston,
Massachusetts
|
+$10.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$43.6M |
| 2 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$38.1M |
| 3 |
PA
Perceptive Advisors
New York
|
-$34.9M |
| 4 |
CAM
Cortina Asset Management
Milwaukee,
Wisconsin
|
-$30.7M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$17.8M |
NXTM Hedge Fund Activity: Q4 2017 in Review
178 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in NxStage Medical Inc. (NXTM) for Q4 2017, worth a combined $1.39B — down 14% from $1.61B a quarter earlier.
Buyers outnumbered sellers: 37 funds opened new NXTM positions and 25 closed out — a net gain of 12 holders — while 62 added to existing stakes and 50 trimmed.
The largest buyer was TIG Advisors LLC, opening a new position worth an estimated $22.8M. The largest seller was Deerfield Management, exiting entirely with an estimated $43.6M sold.
- 178 institutional investors held NxStage Medical Inc. (NXTM) as of Q4 2017, up from 168 in Q3 2017.
- Funds reported $1.39B of NxStage Medical Inc. stock for Q4 2017, down 14% quarter-over-quarter.
- 37 funds opened new NxStage Medical Inc. positions in Q4 2017 and 25 closed out, a net change of +12 holders.
- The largest NxStage Medical Inc. buyer in Q4 2017 was TIG Advisors LLC, an estimated $22.8M added.
- The largest NxStage Medical Inc. seller in Q4 2017 was Deerfield Management, an estimated $43.6M sold.
Based on aggregated 13F filings for Q4 2017.